The application dimension of Handheld Portable Spirometer segmentation is anchored by four principal use‑cases: hospital/clinical diagnostics, home health monitoring, research and clinical trials, and telehealth/remote care. Hospital and clinical environments dominate the market, accounting for roughly 45% of total sales, driven by the need for rapid, point‑of‑care lung function assessment in emergency rooms, intensive care units, and outpatient clinics. Home health monitoring contributes about 30%, reflecting the growing prevalence of chronic respiratory diseases such as COPD and asthma, where patients perform regular spirometry to track disease progression and adjust therapy. Research and clinical trial applications represent 15% of the market; these projects demand high‑precision, reproducible data, prompting adoption of calibrated handheld devices for multicenter studies. Telehealth, encompassing remote patient management platforms, holds a 10% share, expanding as broadband penetration and reimbursement policies improve. Collectively, these application segments shape the overall Handheld Portable Spirometer market size, with each segment’s growth trajectory linked to clinical guidelines, demographic aging, and digital health integration.